-- Sales from products manufactured using 90nm and 65nm process technologies reached record levels in the June quarter exceeding 40% of total sales, up from 26% in the same quarter a year ago. Xilinx's successful introduction of the Virtex-5 family in May 2006 has enabled the Company to achieve significant 65nm sales leadership over PLD competitors. Xilinx estimates that it currently supplies approximately 90% of the PLD industry's 65nm sales. Virtex-5 devices continue to generate strong design win momentum across a broad range of end markets.
-- Industrial and Other sales reached record levels in the June quarter driven by growth from the defense, industrial, scientific and medical applications. Xilinx FPGAs are ideally suited for many of the applications in this space due to their high DSP performance, embedded processing functionality and integration capabilities. Sales from Industrial and Other applications represented 33% of total sales in the June quarter, up from 22% three years ago.
Key Statistics:
Q1 Q4 Q1
FY 2009 FY 2008 FY 2008
Annual Return on Equity (%)* 20 22 18
Operating Cash Flow ($M) 158 102 126
Depreciation Expense ($M) 15 14 12
Capital Expenditures ($M) 10 6 16
Combined Inventory Days 93 92 101
Revenue Turns (%) 59 60 57
*Return on equity calculation: Annualized net income/average stockholders'
equity
Business Outlook -- September Quarter Fiscal 2009
-- Revenues are expected to be between up 1% to down 3% sequentially.
-- Gross margin is expected to be in the range of 63% to 64%.
-- Operating expenses are expected to be approximately $180 million
including $1 million to $2 million of previously announced
restructuring charges.
-- Other income including interest expense is expected to be approximately
$5 million.
-- Tax rate is expected to be approximately 22%.
-- Fully diluted share count is expected to be approximately 277 million
shares.
This release contains forward-looking statements and projections. Forward-looking statements and projections can often be identified by the use of forward-looking words such as "expect," "may," "will," "could," "believe," "anticipate," "estimate," "continue," "plan," "intend," "project" or other similar words. Undue reliance should not be placed on such forward-looking statements and projections, which speak only as of the date they are made. We undertake no obligation to update such forward-looking statements. Actual events and results may differ materially from those in the forward-looking statements and are subject to risks and uncertainties including the general health of global economies as well as of the semiconductor industry, the health of our end markets and our customers' customers, our ability to forecast end customer demand, customer acceptance of our new products, the ability of our customers to manage their inventories, a high dependence on turns business, more customer volume discounts than expected, greater product mix changes than anticipated, fluctuations in manufacturing yields, our ability to deliver product in a timely manner, our ability to successfully manage production at multiple foundries, variability in wafer pricing, and other risk factors listed in our most recent Form 10-K.
About Xilinx
Xilinx, Inc. (NASDAQ: XLNX) is the worldwide leader of programmable logic solutions. Additional information about Xilinx is available at http://www.xilinx.com.
Xilinx, the Xilinx logo, Virtex, Spartan, ISE, and other brands designated herein are trademarks of Xilinx in the United States and other countries. All other trademarks are the property of their respective owners.
#0866F
Investor Relations Contact:
Lori Owen
Xilinx, Inc.
(408) 879-6911
ir@xilinx.com
XILINX, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
(In thousands, except per share amounts)
Three Months Ended
June 28, March 29, June 30,
2008 2008 2007
Net revenues $488,246 $475,760 $445,912
Cost of revenues 176,506 173,974 168,478
Gross margin 311,740 301,786 277,434
Operating expenses:
Research and development 90,734 90,888 87,870
Selling, general and
administrative 93,004 92,469 90,199
Amortization of acquisition-
related intangibles 1,425 1,426 1,897
Restructuring charges 19,536 - -
Total operating expenses 204,699 184,783 179,966
Operating income 107,041 117,003 97,468
Impairment loss on investments (4,621) (2,850) -
Interest and other, net 5,705 5,328 13,533
Income before income taxes 108,125 119,481 111,001
Provision for income taxes 24,196 23,002 26,723
Net income $83,929 $96,479 $84,278
Net income per common share:
Basic $0.30 $0.34 $0.28
Diluted $0.30 $0.34 $0.28
Cash dividends declared per common
share $0.14 $0.12 $0.12
Shares used in per share calculations:
Basic 278,165 284,523 297,720
Diluted 280,881 286,321 303,198
XILINX, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
June 28, March 29,
2008 2008
(Unaudited) (1)
ASSETS
Current assets:
Cash, cash equivalents and short-
term investments $1,238,713 $1,296,435
Accounts receivable, net 205,480 249,147
Inventories 140,372 130,250
Deferred tax assets and other
current assets 147,933 144,364
Total current assets 1,732,498 1,820,196
Net property, plant and equipment 398,882 404,430
Long-term investments 607,253 564,269
Other assets 352,422 348,212
Total Assets $3,091,055 $3,137,107
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued
liabilities $237,681 $228,988
Deferred income on shipments to
distributors 99,789 111,678
Total current liabilities 337,470 340,666
Convertible debentures 999,552 999,851
Deferred tax liabilities 100,548 84,486
Other long-term liabilities 43,894 40,281
Stockholders' equity 1,609,591 1,671,823
Total Liabilities and Stockholders'
Equity $3,091,055 $3,137,107
(1) Derived from audited financial statements
XILINX, INC.
SUPPLEMENTAL FINANCIAL INFORMATION
(Unaudited)
(In thousands)
Three Months Ended
June 28, March 29, June 30,
2008 2008 2007
SELECTED CASH FLOW INFORMATION:
Depreciation $15,420 $13,876 $12,446
Amortization 4,226 4,219 4,605
Stock-based compensation 14,164 17,697 16,521
Net cash provided by operating
activities 158,497 101,841 126,324
Purchases of property, plant and
equipment (9,873) (6,238) (15,599)
Payment of dividends to
stockholders (38,928) (34,093) (35,718)
Repurchases of common stock (150,000) (200,000) -
Proceeds from issuance of common
stock to employees and excess tax
benefit 31,531 57,700 48,046
STOCK-BASED COMPENSATION INCLUDED IN:
Cost of revenues $1,582 $1,820 $2,171
Research and development 6,354 8,908 7,301
Selling, general and administrative 6,228 6,970 7,048
Web site: http://www.xilinx.com/
